88
Views
12
CrossRef citations to date
0
Altmetric
Original Research

The annual direct costs of stable COPD in Greece

, , , , &
Pages 309-315 | Published online: 15 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Shahid Shah, Sameen Abbas, Irfhan Ali Bin Hyder Ali & Ahmad Salman. (2020) The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 661-672.
Read now
Lirong Liang, Yunxiao Shang, Wuxiang Xie, Julie Shi, Zhaohui Tong & Mohammad S Jalali. (2020) Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1165-1175.
Read now
Jing Zhang, Wanzhen Yao, Xuedan You, Tianyi Liu & Yuantao Liu. (2019) Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1195-1207.
Read now

Articles from other publishers (9)

Nikolaos Tzanakis, Epameinontas Kosmas, Andriana I. Papaioannou, Georgios Hillas, Eleftherios Zervas, Stelios Loukides, Petros Bakakos, Paraskevi Katsaounou, Afroditi Boutou, Photis Perlikos, Nikolleta Rovina, Katerina Dimakou, Paschalis Steiropoulos, Grigorios Stratakos, Philipos Emmanouil, Stavros Tryfon & Nikolaos Koulouris. (2022) Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community. Journal of Personalized Medicine 12:12, pages 1997.
Crossref
Chen-Yu Wang, Chen Liu, Hsien-Hui Yang, Pei-Ying Tseng & Jong-Yi Wang. (2022) The Association between Medical Utilization and Chronic Obstructive Pulmonary Disease Severity: A Comparison of the 2007 and 2011 Guideline Staging Systems. Healthcare 10:4, pages 721.
Crossref
Celia Gutiérrez Villegas, María Paz-Zulueta, Manuel Herrero-Montes, Paula Parás-Bravo & María Madrazo Pérez. (2021) Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Economics Review 11:1.
Crossref
Joseph Kazibwe, Phuong Bich Tran & Kristi Sidney Annerstedt. (2021) The household financial burden of non-communicable diseases in low- and middle-income countries: a systematic review. Health Research Policy and Systems 19:1.
Crossref
E. A. Orlova, A. R. Umerova, I. P. Dorfman, M. A. Orlov & M. A. Abdullaev. (2021) ЕSTIMATION OF SOCIO-ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOR A 5-YEAR PERIOD: A REGIONAL ASPECT. Pharmacy & Pharmacology 9:2, pages 130-138.
Crossref
Kate M. Johnson, Mohsen Sadatsafavi, Amin Adibi, Larry Lynd, Mark Harrison, Hamid Tavakoli, Don D. Sin & Stirling Bryan. (2020) Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD. Applied Health Economics and Health Policy 19:2, pages 203-215.
Crossref
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sabariah Noor Harun, Shahid Shah & Sameen Abbas. (2019) The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. The European Journal of Health Economics 21:2, pages 181-194.
Crossref
Kyriakos Souliotis, Luís Silva Miguel, Georgios Hillas, Margarida Borges, Giannis Papageorgiou, Diogo Viana, Joao Malhadeiro & Stéphane Soulard. (2020) The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 14, pages 175346662092680.
Crossref
Georgia Kourlaba, Georgios Hillas, Theodoros Vassilakopoulos & Nikos Maniadakis. (2018) The Economic Burden of Chronic Obstructive Pulmonary Disease in Greece. Applied Health Economics and Health Policy 17:1, pages 111-121.
Crossref